Real Journeys, Real Outcomes | Inspiring Transformations with EllieMD Customers In this episode of Real Journeys, Real Outcomes, three EllieMD customers Jennifer Gifford Wersland, Rich Feld, and Rhonda Leafstone share their personal experiences using peptides and personalized wellness tools to boost energy, speed up recovery, and cultivate long-term vitality.Disclaimer:This video is for educational and informational purposes only and is not intended as medical advice
Public Docket FDA-2025-N-6895 Written comments on BPC-157 and the other peptides under review can be submitted to public docket FDA-2025-N-6895
The absence of published, large-scale human trials means that its use in clinical practice remains on the frontier of peptide medicine
If the PCAC issues favorable recommendations and the FDA subsequently reclassifies any of these peptides into Category 1, the availability of pharmaceutical-grade API will likely become the principal bottleneck governing how quickly compounding pharmacies can bring compliant products to market
Contraindications to GLP-1 receptor agonists include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastroparesis
Ipamorelin: The clean GH releaser Ipamorelin stimulates natural growth hormone release without many side effects associated with other secretagogues